• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NTI 1.89% 5.4¢

NEUROTECH INTERNATIONAL LIMITED

Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical... Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical development company. The Company is focused predominately on pediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy called NTI164. It has completed a Phase II/III randomized, double-blind, placebo-controlled clinical trial in autism spectrum disorder (ASD) with clinically significant benefits reported across a number of clinically validated measures and safety. In addition, it has completed and reported significant and clinically meaningful Phase I/II trials in ASD and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS), collectively PANDAS/PANS along with Rett Syndrome. NTI164 is being developed as a therapeutic drug product for a range of neurological disorders in children where neuroinflammation is involved.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) reports record revenue growth, European market expansion and strategic cost savings

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NTI
Just Cheap or Just dreaming
16:01 10 5.5K
16:01 Last post  glory Comments Created with Sketch.  10  Views Created with Sketch.  5.5K 
NTI 03/11/24 6 2.1K
03/11/24 Last post  greedy Comments Created with Sketch.  6  Views Created with Sketch.  2.1K 
NTI 21/10/24 8 2.8K
21/10/24 Last post  Ozibobby Comments Created with Sketch.  8  Views Created with Sketch.  2.8K 
NTI 17/10/24 2 657
17/10/24 Last post  Bluebush Comments Created with Sketch.  2  Views Created with Sketch.  657 
NTI
Update on Legal Dispute
12/10/24 3 1.1K
12/10/24 Last post  greedy Comments Created with Sketch.  3  Views Created with Sketch.  1.1K 
NTI 10/10/24 2 1.0K
10/10/24 Last post  Vanimo Comments Created with Sketch.  2  Views Created with Sketch.  1.0K 
NTI 05/10/24 15 5.5K
05/10/24 Last post  Vanimo Comments Created with Sketch.  15  Views Created with Sketch.  5.5K 
NTI 05/10/24 29 8.5K
05/10/24 Last post  TerribleTadpole Comments Created with Sketch.  29  Views Created with Sketch.  8.5K 

See All Discussions arrow Created with Sketch.

Timeline

Quarterly Activities/Appendix 4C Cash Flow Report
23 Oct 09:28
 
Notice of Annual General Meeting/Proxy Form
16 Oct 17:44
 
Becoming a substantial holder
08 Oct 20:18
 
US FDA Response to Orphan Drug Request in PANDAS/PANS
04 Oct 08:52
 
Upcoming Presentation of Rett Syndrome Clinical Data
24 Sep 09:12
 
Change of Director's Interest Notice
20 Sep 18:25
 
View More arrow Created with Sketch.
(20min delay)
Last
5.4¢
Change
0.001(1.89%)
Mkt cap ! $55.86M
Open High Low Value Volume
5.4¢ 5.4¢ 5.3¢ $8.824K 164.2K

Buyers (Bids)

No. Vol. Price($)
12 2997322 5.3¢
 

Sellers (Offers)

Price($) Vol. No.
5.4¢ 263408 1
View Market Depth
Last trade - 15.34pm 06/11/2024 (20 minute delay) ?
Last
5.4¢
  Change
0.001 ( 0.00 %)
Open High Low Volume
5.4¢ 5.4¢ 5.3¢ 176502
Last updated 15.42pm 06/11/2024 ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.